A failed spinal fusion leaves many patients in a difficult position — pain persists, and the path forward feels unclear. For candidates whose pain stems from unaddressed annular tears, adjacent segment degeneration, or other overlooked sources, advanced non-surgical options such as intra-annular fibrin injection may offer meaningful relief. Outcomes are evaluated individually and vary by case.

The Challenge of Persistent Pain After Spinal Fusion

Spinal fusion is designed to stabilize vertebral segments and reduce pain from instability or severe nerve compression. For some patients it provides significant improvement; for others, pain continues or worsens — a condition commonly called Failed Back Surgery Syndrome (FBSS). The reasons vary widely and understanding them is the first step toward a different path forward.

Common factors that may contribute to ongoing pain after fusion include:

• Non-union (pseudarthrosis): The targeted vertebrae do not fuse completely, which can leave residual instability and pain.
• Adjacent segment disease (ASD): Fusing one spinal level redistributes mechanical stress to the discs and facet joints immediately above and below. Over time, this can accelerate degeneration at those neighboring segments, creating new pain generators.
• Persistent or new nerve compression: Scar tissue, hardware irritation, or incomplete decompression may continue to compress nerve roots even after a technically successful fusion.
• Unaddressed pain sources: Pre-existing annular tears, facet joint arthritis, or sacroiliac (SI) joint dysfunction at levels not targeted by the fusion may continue producing pain.
• Hardware-related issues: Screws or rods can loosen, fracture, or cause local tissue irritation over time.

The physical burden of ongoing pain is substantial, but the emotional weight of a surgery that did not deliver expected results can be equally significant. Many patients feel underserved by conventional follow-up care and struggle to find a clear path forward after investing so much in their original procedure.

Expert Take

Post-fusion pain is not a single diagnosis — it is a category of overlapping problems. Our clinical team focuses on isolating which specific anatomical structure is still generating pain rather than defaulting to a revision surgery recommendation. In many cases, that source turns out to be an annular tear at an adjacent level that was not present — or was not symptomatic — at the time of the original fusion.

Identifying the True Source of Post-Fusion Pain

At Valor Spine, our evaluation process starts with a foundational principle: persistent pain after fusion means the underlying signal is still active, not that treatment options have been exhausted. A thorough diagnostic workup often uncovers pain generators that were either overlooked during initial surgical planning or that developed afterward.

Our comprehensive evaluation typically includes:

• A detailed review of your full medical history, prior operative reports, and imaging
• A focused physical examination assessing pain patterns, range of motion, and neurological function
• Meticulous analysis of current MRI, CT, and X-ray studies — often identifying subtle findings that may have been underweighted previously
• Specialized diagnostic tools such as provocative discography when annular pathology is suspected

Structures our clinical team evaluates carefully in the post-fusion patient include:

• Annular tears at adjacent or remote levels: Small tears in the outer fibrous ring of a disc allow the nucleus pulposus to leak, producing localized inflammation and chronic discogenic pain — even without a frank herniation visible on standard imaging.
• Facet joint syndrome: Arthritis or capsular inflammation in the small posterior joints connecting vertebrae can be a significant independent pain generator.
• Sacroiliac joint dysfunction: The SI joint frequently becomes overloaded after lumbar fusion, and SI-derived pain is often mistaken for residual disc pain.
• Scar tissue and muscle atrophy: Surgical trauma can disrupt the paraspinal musculature and produce adhesions that perpetuate discomfort.
• Chronic neuroinflammation: Ongoing inflammatory signaling around nerve roots or soft tissues can maintain pain cycles independently of structural compression.

For a broader look at lumbar conditions that may contribute to post-fusion pain, see our overview of 10 common lumbar spine conditions causing low back pain.

Regenerative Options for Post-Fusion Pain

For patients whose post-fusion pain is driven by disc pathology — particularly annular tears at adjacent segments — regenerative treatments offer a non-surgical path that targets the structural source of pain rather than simply managing symptoms.

Intra-Annular Fibrin Injection (Biologic Disc Repair)

Annular tear repair using intra-annular fibrin injection is among the most relevant regenerative options for patients with post-fusion discogenic pain. When the outer annular wall tears, the nucleus pulposus can leak inflammatory material into surrounding tissue, producing significant and often chronic pain that does not resolve with rest or conventional injections.

In this procedure, a biologic fibrin sealant is delivered under imaging guidance directly into the damaged disc. Fibrin acts as a structural scaffold, supporting the body’s natural repair process, sealing the tear, and reducing the inflammatory cascade driven by nucleus leak. Because the treatment is minimally invasive and does not alter spinal mechanics, it is particularly relevant for patients who have already undergone fusion and want to avoid further structural disruption.

Candidates for this approach are evaluated individually. Many patients who have undergone prior spinal procedures — including fusion — may still qualify, depending on the location and character of their remaining disc pathology. Our clinical team reviews each case to determine whether intra-annular fibrin injection is appropriate for a given patient’s anatomy and pain profile.

To explore how this approach compares with traditional surgery, visit our detailed resource on biologic disc repair vs. traditional spine surgery.

Adjacent Segment Disease and Fibrin Treatment

Adjacent segment disease is one of the most common sources of new pain after a lumbar or cervical fusion. When imaging and diagnostic testing confirm active annular pathology at an adjacent level, intra-annular fibrin injection may help address the structural source without requiring revision surgery. Our adjacent segment disease fibrin case study illustrates how this evaluation and treatment pathway may unfold for suitable candidates.

Other Regenerative Approaches

Depending on the diagnostic findings, our clinical team may incorporate additional biologic therapies. Facet joint inflammation, SI joint dysfunction, or soft-tissue pain generators may respond to targeted interventional approaches designed to reduce inflammation and support tissue recovery. Each plan is individualized to the patient’s confirmed anatomy, symptom pattern, and treatment history.

For an overview of the broader non-surgical landscape, see our article on 5 non-surgical disc treatments for chronic back pain.

The Valor Spine Approach: Precision Care After Failed Fusion

Patients who arrive at Valor Spine after a failed fusion have often already experienced multiple interventions, repeated imaging studies, and conflicting recommendations. Our clinical process is designed to bring clarity, not add to that burden.

1. Comprehensive consultation: We review your complete surgical history, prior operative and imaging reports, and current symptom profile before drawing any conclusions about diagnosis or candidacy.
2. Advanced imaging analysis: Rather than requesting redundant imaging, we take time to analyze existing studies with a focus on finding what may have been underappreciated — particularly annular pathology, adjacent segment changes, and facet-level degeneration.
3. Individualized treatment planning: If the evaluation identifies a suitable target, we develop a treatment plan centered on the confirmed pain generator. We do not offer a one-size-fits-all protocol. Candidates are evaluated individually, and some patients may not be appropriate for regenerative treatment based on their anatomy or prior surgical changes.
4. Patient-centered communication: We explain our findings in plain language, walk through all available options — including those we offer and those we do not — and help patients make informed decisions about next steps.

Our clinical team’s focus is on helping patients who have been told their only remaining option is revision surgery to understand whether non-surgical alternatives may be appropriate for their specific situation.

Expert Take

A prior fusion does not disqualify a patient from being a candidate for regenerative disc repair at adjacent or remote levels. What matters is whether there is an identifiable, structurally accessible pain source that has not been addressed. In many post-fusion cases, that source is an annular tear — and those tears can often be targeted with a minimally invasive biologic approach without disturbing the existing fusion hardware.

Illustrative Patient Scenarios

The following are representative examples drawn from the types of presentations our clinical team evaluates. They are illustrative scenarios, not individual patient records, and outcomes vary by case.

Scenario: Adjacent Segment Pain After Lumbar Fusion

A patient undergoes L4–L5 fusion that initially resolves severe sciatica. Over the following years, a new lower back pain emerges with radiation into the contralateral thigh. Follow-up MRI shows early degenerative changes at L3–L4. Diagnostic evaluation including discography confirms an active annular tear at L3–L4 as the primary pain source — a finding consistent with adjacent segment disease. For a patient like this, intra-annular fibrin injection targeting the adjacent level may be evaluated as a non-surgical alternative to revision surgery. Whether this approach is appropriate depends on the individual anatomy and tear characteristics.

Scenario: Persistent Discogenic Pain After Fusion

Following lumbar fusion for a severe herniated disc, a patient’s radicular pain resolves but a persistent dull ache in the lower back remains unexplained by standard post-operative imaging. Detailed evaluation identifies multiple low-grade annular tears at other lumbar levels — structurally separate from the fused segment — that were likely present but asymptomatic before surgery. Targeted fibrin disc treatment addressing these previously undiagnosed tears may help reduce discogenic pain in patients whose post-fusion ache has no other identified structural explanation. Outcomes vary, and candidacy is assessed individually.

Scenario: Post-Fusion Pain in a Veteran with Service-Connected Disc Disease

Veterans with service-connected spinal conditions carry a disproportionate burden of chronic back pain and are at elevated risk for inadequate symptom control after fusion. A veteran who undergoes lumbar fusion and continues to experience significant pain may have persistent annular pathology at adjacent levels that was not the focus of the original surgical plan. For suitable veteran candidates, biologic disc repair may offer a path to meaningful pain reduction without repeat open surgery. Our team evaluates veteran patients using the same individualized diagnostic approach as civilian patients and can discuss applicable VA community care coverage options during consultation.

For more on non-surgical care pathways specific to veterans, see our guide on non-surgical back pain relief options for veterans.

Taking the Next Step

Living with chronic pain after a spinal fusion can feel isolating — particularly when conventional follow-up offers only symptom management or revision surgery as options. At Valor Spine, we believe a failed fusion is a diagnostic challenge, not a final verdict.

Our clinical team evaluates each patient’s complete picture — prior surgeries, current imaging, confirmed pain generators — and determines whether a non-surgical regenerative approach is appropriate for that individual. For patients with active annular pathology at levels adjacent to or separate from a prior fusion, intra-annular fibrin injection may provide a meaningful path toward reduced pain and improved function. Outcomes vary by case, and not every patient with a failed fusion will be a candidate for this approach.

If you would like to understand whether you may qualify, we encourage you to schedule a consultation with our clinical team.

For additional perspective on avoiding repeat surgeries, see 5 things to consider about avoiding failed back surgery with regenerative disc repair first and our resource on regenerative options after a failed fusion.